Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2

Cancer Cell

Volumn 6, Issue 3, 2004, Pages 251-261

  Wang, Shao Chun ^a   Lien, Huang Chun ^a   Xia, Weiya ^a   Chen, I Fen ^a   Lo, Hui Wen ^a   Wang, Zhiqin ^a   Ali Seyed, Mohamed ^a   Lee, Dung Fang ^a,b   Bartholomeusz, Geoffrey ^a   Ou Yang, Fu ^a   Giri, Dipak K ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TYROSINE KINASE RECEPTOR;

ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 4544376914     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.07.012     Document Type: Article

References (47)

1. Abe Y., Matsumoto S., Wei S., Nezu K., Miyoshi A., Kito K., Ueda N., Shigemoto K., Hitsumotol Y., Nikawa J.-i., Enomoto Y. Cloning and characterization of a p53-related protein kinase expressed in interleukin-2-activated cytotoxic T-cells, epithelial tumor cell lines, and the testes. J. Biol. Chem. 276:2001;44003-44011
2. Ahmad S.I., Hanaoka F., Kirk S.H. Molecular biology of Fanconi anaemia - an old problem, a new insight. Bioessays. 24:2002;439-448
3. Arteaga C.L. ErbB-targeted therapeutic approaches in human cancer. Exp. Cell Res. 284:2003;122-130
4. Berry M., Nunez A.-M., Chambon P. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA. 86:1989;1218-1222
5. Blagoev B., Kratchmarova I., Ong S.E., Nielsen M., Foster L.J., Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 21:2003;315-318
6. Carpenter G. Nuclear localization and possible functions of receptor tyrosine kinases. Curr. Opin. Cell Biol. 15:2003;143-148
7. Chen X., Leung S.Y., Yuen S.T., Chu K.M., Ji J., Li R., Chan A.S., Law S., Troyanskaya O.G., Wong J., et al. Variation in gene expression patterns in human gastric cancers. Mol. Biol. Cell. 14:2003;3208-3215
8. Clevenger C.V. Nuclear localization and function of polypeptide ligands and their receptors. a new paradigm for hormaone specificity within the mammary gland? Breast Cancer Res. 5:2003;181-187
9. Endo K., Yoon B.I., Pairojkul C., Demetris A.J., Sirica A.E. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology. 36:2002;439-450
10. Feng Y., Venema V.J., Venema R.C., Tsai N., Caldwell R.B. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells. Biochem. Biophys. Res. Commun. 256:1999;192-197
11. Flower R.J. The development of COX2 inhibitors. Nat. Rev. Drug Discov. 2:2003;179-191
12. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 19:2000;19-27
13. Graus-Porta D., Beerli R.R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 16:1997;1647-1655
14. Half E., Tang X., Gwyn K., Sahin A., Wathen K., Sinicrope F.A. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res. 62:2002;1676-1681
15. Hata A., Seoane J., Lagna G., Montalvo E., Hemmati-Brivanlou A., Massague J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell. 100:2000;229-240
16. Holbro T., Civenni G., Hynes N.E. The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284:2003;99-110
17. Howe L.R., Subbaramaiah K., Brown A.M., Dannenberg A.J. Cyclooxygenase-2. a target for the prevention and treatment of breast cancer Endocr. Relat. Cancer. 8:2001;97-114
18. Jones D.A., Carlton D.P., McIntyre T.M., Zimmerman G.A., Prescott S.M. Molecular cloning of human prostaglandin endoperoxidase synthase type 2 and demonstration of expression in response to cytokines. J. Biol. Chem. 268:1993;9049-9054
19. Keresztes M., Boonstra J. Import(ance) of growth factors in(to) the nucleus. J. Cell Biol. 145:1999;421-424
20. Kiguchi K., Carbajal S., Chan K., Beltran L., Ruffino L., Shen J., Matsumoto T., Yoshimi N., DiGiovanni J. Constitutive expression of ErbB-2 in gallbladder epithelium results in development of adenocarcinoma. Cancer Res. 61:2001;6971-6976
21. Kimura H. Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc. Natl. Acad. Sci. USA. 90:1993;2165-2169
22. Klapper L.N., Waterman H., Sela M., Yarden Y. Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2. Cancer Res. 60:2000;3384-3388
23. Levitzki A., Gazit A. Tyrosine kinase inhibition. an approach to drug development Science. 267:1995;1782-1788
24. Lin S.-Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., Bourguignon L., Hung M.-C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 3:2001;802-808
25. Maher P.A. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol. 134:1996;529-536
26. Mendelsohn J., Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 19:2000;6550-6565
27. Ni C.-Y., Murphy M.P., Golde T.E., Carpenter G. γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science. 294:2001;2179-2181
28. Offterdinger M., Schöfer C., Weipoltshammer K., Grunt T.W. c-erbB-3. a nuclear protein in mammary epithelial cells J. Cell Biol. 157:2002;929-939
29. Pagano G., Youssoufian H. Fanconi anaemia proteins. major roles in cell protection against oxidative damage Bioessays. 25:2003;589-595
30. Rajnish A., Gupta R.A., DuBois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer. 1:2001;11-21
31. Rakowicz-Szulczynska E.M., Herlyn M., Koprowski H. Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes, and colorectal carcinoma cells in vitro. Cancer Res. 48:1988;7200-7206
32. Reilly J.F., Maher P.A. Importin β-mediated nuclear import of fibroblast growth factor receptor. role in cell proliferation J. Cell Biol. 152:2001;1307-1312
33. Ristimäki A., Sivula A., Lundin J., Lundin M., Salminen T., Haglund C., Joensuu H., Isola J. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 62:2002;632-635
34. Savitsky K., Ziv Y., Bar-Shira A., Gilad S., Tagle D.A., Smith S., Uziel T., Sfez S., Nahmias J., Sartiel A., et al. A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23. Genomics. 33:1996;199-206
35. Subbaramaiah K., Norton L., Gerald W., Dannenberg A.J. Cyclooxygenase-2 is overexpressed in c-erbB-2-positive breast cancer. J. Biol. Chem. 277:2002;18649-18657
36. Takahashi Y., Kawahara F., Noguchi M., Miwa K., Sato H., Seiki M., Inoue H., Tanabe T., Yoshimoto T. Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2. FEBS Lett. 460:1999;145-148
37. Tan M., Yao J., Yu D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res. 57:1997;1199-1205
38. Tsujii M., Kawano S., DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increase metastatic potential. Proc. Natl. Acad. Sci. USA. 94:1997;3336-3340
39. Turini M.E., DuBois R.N. Cyclooxygenase-2. a therapeutic target Annu. Rev. Med. 53:2002;35-57
40. Vadlamudi R., Mandal M., Adam L., Steinbach G., Mendelsohn J., Kumar R. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene. 18:1999;305-314
41. Weinmann A.S., Bartley S.M., Zhang T., Zhang M.Q., Farnham P.J. Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell. Biol. 21:2001;6820-6832
42. Wells A., Marti U. Signalling shortcuts. cell-surface receptors in the nucleus? Nat. Rev. Mol. Cell Biol. 3:2002;1-6
43. Will H., Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231:1995;602-608
44. Xie Y., Hung M.-C. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem. Biophys. Res. Commun. 203:1994;1589-1598
45. Yamamoto T., Ikawa S., Akiyama T., Semba K., Nomura N., Miyajima N., Saito T., Toyoshima K. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature. 319:1986;230-234
46. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2:2001;127-137
47. Zhong S., Salomoni P., Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2:2000;E85-E90